• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿曼一个患有阵发性非运动诱发性运动障碍的家族中的肌原纤维生成调节因子1基因(MR-1)突变

Myofibrillogenesis regulator 1 gene (MR-1) mutation in an Omani family with paroxysmal nonkinesigenic dyskinesia.

作者信息

Hempelmann Anne, Kumar Santosh, Muralitharan Shanmugakonar, Sander Thomas

机构信息

Gene Mapping Center, Max-Delbrück-Center for Molecular Medicine, Department of Neurology, Charité University Medicine, Berlin, Germany, and Department of Neurology, The Royal Hospital, Muscat, Oman.

出版信息

Neurosci Lett. 2006 Jul 10;402(1-2):118-20. doi: 10.1016/j.neulet.2006.03.048. Epub 2006 Apr 24.

DOI:10.1016/j.neulet.2006.03.048
PMID:16632198
Abstract

Two recurrent missense mutations (c.20C>T: A7V; c.26C>T: A9V) in the gene encoding the myofibrillogenesis regulator 1 (MR-1) have been shown to cause autosomal dominant paroxysmal nonkinesigenic dyskinesia (PNKD) in 13 families of primarily European ancestry. Here we report an Omani PNKD family with seven affected family members and autosomal dominant inheritance. Our linkage analysis provided consistent positional evidence that the MR-1 gene could be the responsible disease gene. Sequence analysis identified a MR-1 missense mutation (c.20C>T; A7V) in the affected family members, whereas it was not present in five unaffected family members and 129 population controls. Taking into account that previous haplotype analyses did not reveal evidence for common founders among several PNKD families, our present findings strengthen three implications: (1) autosomal dominant PNKD seems to be a homogenous disorder, for which the MR-1 gene is the major disease gene; (2) mainly two recurrent MR-1 missense mutations (57% V7, 43% V9) account for the genetic variance of familial PNKD; (3) it supports current evidence that some of the recurrent MR-1 mutations may have arisen independently by de novo mutation at functionally convergent key sites of the brain-specific MR-1L isoform.

摘要

编码肌原纤维生成调节因子1(MR-1)的基因中有两个反复出现的错义突变(c.20C>T:A7V;c.26C>T:A9V),已证实在13个主要为欧洲血统的家族中可导致常染色体显性遗传性发作性非运动诱发性运动障碍(PNKD)。在此,我们报告一个阿曼PNKD家族,该家族有7名受影响的家族成员,呈常染色体显性遗传。我们的连锁分析提供了一致的定位证据,表明MR-1基因可能是致病基因。序列分析在受影响的家族成员中鉴定出一个MR-1错义突变(c.20C>T;A7V),而在5名未受影响的家族成员和129名人群对照中未发现该突变。鉴于之前的单倍型分析未揭示几个PNKD家族中有共同的奠基者证据,我们目前的研究结果强化了三点启示:(1)常染色体显性遗传性PNKD似乎是一种同质疾病,MR-1基因是主要致病基因;(2)主要有两个反复出现的MR-1错义突变(57%为V7,43%为V9)导致家族性PNKD的遗传变异;(3)这支持了当前的证据,即一些反复出现的MR-1突变可能是在脑特异性MR-1L亚型的功能趋同关键位点通过新发突变独立产生的。

相似文献

1
Myofibrillogenesis regulator 1 gene (MR-1) mutation in an Omani family with paroxysmal nonkinesigenic dyskinesia.阿曼一个患有阵发性非运动诱发性运动障碍的家族中的肌原纤维生成调节因子1基因(MR-1)突变
Neurosci Lett. 2006 Jul 10;402(1-2):118-20. doi: 10.1016/j.neulet.2006.03.048. Epub 2006 Apr 24.
2
Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds.阵发性非运动诱发性运动障碍中肌原纤维生成调节因子1存在丙氨酸至缬氨酸替代:在两个家系中的证实
Arch Neurol. 2005 Apr;62(4):597-600. doi: 10.1001/archneur.62.4.597.
3
Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in Serbian family with Myofibrillogenesis regulator 1 gene mutation.塞尔维亚一个患有肌原纤维生成调节因子1基因突变家族的阵发性非运动诱发性运动障碍的临床特征
Mov Disord. 2006 Nov;21(11):2010-5. doi: 10.1002/mds.21095.
4
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia.阵发性非运动诱发性运动障碍的基因型-表型相关性
Neurology. 2007 May 22;68(21):1782-9. doi: 10.1212/01.wnl.0000262029.91552.e0.
5
A case of familial paroxysmal nonkinesigenic dyskinesia due to mutation of the PNKD gene in Chinese Mainland.中国大陆地区因PNKD基因突变导致的家族性阵发性非运动诱发性运动障碍1例。
Brain Res. 2015 Jan 21;1595:120-6. doi: 10.1016/j.brainres.2014.07.047. Epub 2014 Aug 5.
6
Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia.阵发性非运动诱发性运动障碍的遗传异质性。
Neurology. 2006 May 23;66(10):1588-90. doi: 10.1212/01.wnl.0000217332.51740.7c.
7
Familial paroxysmal nonkinesigenic dyskinesia: clinical and genetic analysis of a Taiwanese family.家族性发作性非运动性舞蹈手足徐动症:一个台湾家族的临床和遗传学分析。
J Neurol Sci. 2012 Dec 15;323(1-2):80-4. doi: 10.1016/j.jns.2012.08.015. Epub 2012 Sep 8.
8
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway.阵发性非运动诱发性运动障碍基因在应激反应途径中编码一种酶。
Hum Mol Genet. 2004 Dec 15;13(24):3161-70. doi: 10.1093/hmg/ddh330. Epub 2004 Oct 20.
9
Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence.阵发性非运动诱发性运动障碍由MR-1线粒体靶向序列的突变引起。
Hum Mol Genet. 2009 Mar 15;18(6):1058-64. doi: 10.1093/hmg/ddn441. Epub 2009 Jan 5.
10
Spinocerebellar ataxias type 27 derived from a disruption of the fibroblast growth factor 14 gene with mimicking phenotype of paroxysmal non-kinesigenic dyskinesia.27型脊髓小脑共济失调源于成纤维细胞生长因子14基因的破坏,具有发作性非运动诱发性运动障碍的模拟表型。
Brain Dev. 2012 Mar;34(3):230-3. doi: 10.1016/j.braindev.2011.04.014. Epub 2011 May 19.

引用本文的文献

1
Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics.评估科威特人群中的编码区变异:对医学遗传学和群体基因组学的影响。
Sci Rep. 2018 Nov 8;8(1):16583. doi: 10.1038/s41598-018-34815-8.
2
The PNKD gene is associated with Tourette Disorder or Tic disorder in a multiplex family.PNKD 基因与多发性家族中的抽动秽语综合征或抽动障碍有关。
Mol Psychiatry. 2018 Jun;23(6):1487-1495. doi: 10.1038/mp.2017.179. Epub 2017 Sep 12.
3
The genetics of dystonia: new twists in an old tale.扭转痉挛的遗传学:旧故事的新转折。
Brain. 2013 Jul;136(Pt 7):2017-37. doi: 10.1093/brain/awt138. Epub 2013 Jun 17.
4
Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia.阵发性运动源性运动障碍小鼠模型中的多巴胺失调。
J Clin Invest. 2012 Feb;122(2):507-18. doi: 10.1172/JCI58470. Epub 2012 Jan 3.
5
Analyzing clinical and electrophysiological characteristics of Paroxysmal Dyskinesia.分析发作性运动障碍的临床和电生理特征。
J Res Med Sci. 2011 Jan;16(1):110-4.
6
Genetics of paroxysmal dyskinesias.阵发性运动障碍的遗传学
Curr Neurol Neurosci Rep. 2009 May;9(3):206-11. doi: 10.1007/s11910-009-0031-8.